Skip to main content

Table 1 Summary of patient characteristics

From: Preoperative exercise therapy for gastrointestinal cancer patients: a systematic review

Study Patient population Groups N Age (year) % male ASA > II BMI (kg/m2)
Carli et al. Benign or malignant colorectal cancer Intervention 58 61 ± 16 59 22% 28 ± 6
Control 54 60 ± 15 57 20% 27 ± 5
Cho et al. Gastric cancer Intervention 18 63.1 (51–76)* 100 NR 26.7 (23.1–31.2)*
Control 54 66.1 (39–81)* 94.4 NR 25.7 (20.8–34.1)*
Dronkers et al. Colon cancer Intervention 22 71.1 ± 6.3 68.2 NR 26.6 ± 3.6
Control 20 68.8 ± 6.4 80 NR 25.6 ± 3.1
Gillis et al. Colorectal cancer Intervention 38 65.7 ± 13.6 55 26% 26.9 ± 4.6
Control 39 66.0 ± 9.1 69 23% 28.5 ± 4.3
Kaibori et al. Hepatocellular carcinoma Intervention 25 68 ± 9.1 68 NR NR
Control 26 71.3 ± 8.8 73 NR NR
Kim et al. Benign or malignant colorectal cancer Intervention 14 55 ± 15 64 NR 26.6 ± 5.9
Control 7 65 ± 9 57 NR 25.3 ± 2.7
Li et al. Colorectal cancer Intervention 42 67.4 ± 11 54 19% 27.5 ± 4
Control 45 66.4 ± 12 64 22% 26.9 ± 6
West et al. Rectal cancer treated with NACRT Intervention 22 64 (45–82)* 64 9% NR
Control 13 72 (62–84) 69 15% NR
Dunne et al. Colorectal liver metastasis Intervention 20 61 (56–66)* 65 NR 29.2 ± 4.1
Control 17 62 (53–72)* 77 NR 29.3 ± 4.2
  1. Age and BMI values are presented as mean ± standard deviation, unless otherwise noted
  2. *Range reported, rather than standard deviation
  3. NACRT neoadjuvant chemoradiotherapy, NR not reported, BMI body mass index, ASA American Society of Anesthesiologist class